Off-topic for aiqbench

This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.

Sedai Signs Collaboration and Licensing Agreement with Johnson & Johnson

36KrOctober 9, 20261 min read

36Kr reports that Sedai (Nanjing) Pharmaceutical Technology Co., Ltd. announced that the company and its wholly-owned subsidiary, Sedai (Shanghai) Pharmaceutical Technology Co., Ltd., have signed a collaboration and licensing agreement with Johnson & Johnson. The two parties will jointly develop new oral medications. Concurrently, JJDC, Johnson & Johnson's venture investment arm, made an equity investment in Sedai.

Read the full article at 36Kr

Read at 36Kr ↗Ask about this article